SECTION 1 - EXECUTIVE SUMMARY
- The 25-second Read
- Size & Pace (Who Contributes What by 2032)
- Where Growth Concentrates
- Country/Cluster Snapshots
- APAC Watchlist (What to Act on in the Next 12 months)
- Pulse Quick Actions (12 Months)
SECTION 2 - RESEARCH METHODOLOGY
- Objective
- Dual-lens Architecture
- APAC-specific Evidence & Inputs
- Model Calibration Choices (APAC)
- Limitations & Mitigations (APAC)
- Quality Assurance Loop
SECTION 3 - ASIA-PACIFIC (APAC) MARKET
- Size, Trajectory & Strategic Importance
- Demand Drivers & Headwinds
- Competitive & Partnership Landscape
- Strategic Clustering & Go-to-Market Nuances
- Strategic Recommendations
- Regulatory / Policy (What’s New or Clarified)
- AI Imaging Market by Country - APAC
- Markintel GTM Growth and Maturity Matrix - APAC
- Competitive Data Set - APAC
- Numbers-in-Context - APAC
- Strategic Takeaways - APAC
- Growth & Maturity Highlights - APAC
- M&A Watchlist - APAC
- Regulatory Velocity - APAC
- OEM AI Attach Rate - APAC
- Attach-Rate Trends - APAC
- Factory vs Retrofit Attach
- GTM at-a-Glance - APAC
- GTM Readiness Radar - APAC
- Tiered Customer Landscape - APAC
- GTM Timeline - APAC
- Adjacency Opportunity Matrix - APAC
- Country-Cluster Framework - APAC
- White Space Partner Framework - APAC
- Regulatory Funding Heatmap - APAC
- Channel x Pricing Matrix - APAC
- Fast Strategic Cues - APAC
SECTION 4 - CHINESE MARKET
- China - Market Overview & Strategic Summary (2023-2032)
- Urban-Rural Duality Matters
- Strategic Takeaways
- Chinese Market Forecasts (2023-2032)
- Chinese Market by Clinical Area (2023-2032)
- Chinese Market by Modality (2023-2032)
- Chinese Market by Revenue Stream (2023-2032)
- Chinese Market by Clinical Application (2023-2032)
- Chinese Market by End-Use Organization (2023-2032)
- Chinese Market by AI Technology (2023-2032)
- Markintel Growth Maturity Matrix - China AI in Medical Imaging
- Executive Commentary
- Cross-Quadrant Insights & Tactical Guidance
- Priority Recommendations (next 18 months)
- Competitive Dataset - China
- Markintel Ecosystem Collaboration Matrix - China
- Decoding the 2 × 2 and Turning it into Action
- Three Rules for Winning the Collaboration Game
- Quick hit Actions for BD teams (Next Two Quarters)
- Markintel Solution Adoption and Growth Matrix - China
- Translating the Matrix into Action
- Execution Priorities by Function
- “First 100-Days” Checklist
- Metrics that Matter
- Operating Roadmap Takeaway
- GTM at a Glance - China
- GTM Readiness Radar - China
- Tiered Customer Landscape - China
- GTM Timeline - China
- Adjacency-Opportunity Radar - China
- Regulatory Funding Heatmap - China
- Channel × Pricing Matrix - China
- White Space Partnership Matrix - China
SECTION 5 - JAPANESE MARKET
- Market Overview & Strategic Summary: Japan
- Strategic Outlook
- Action Points
- Japanese Market Forecasts (2023-2032)
- Japanese Market by Clinical Area (2023-2032)
- Japanese Market by Modality (2023-2032)
- Japanese Market by Clinical Application (2023-2032)
- Japanese Market by End-Use Organization (2023-2032)
- Japanese Market by AI Technology (2023-2032)
- Markintel Solution Adoption & Growth Matrix - Japan
- Turning the Matrix into an Operating Road Map for Japan (2024 28)
- Markintel Ecosystem Collaboration Matrix - Japan
- Turning the Matrix into an Operating Roadmap
- Playbook Highlights by Quadrant
- Risk Checkpoints & Mitigations
- Go-to-Market (GTM) Playbook - Japan
- GTM Readiness Radar - Japan
- Tiered Customer Landscape - Japan
- GTM Timeline - Japan
- Adjacency Opportunity Radar - Japan
- Regulatory Funding Heatmap - Japan
- Channel x Pricing Matrix - Japan
- White Space Partnership Matrix - Japan
- Fast Strategic Cues
SECTION 6 - INDIAN MARKET
- Market Overview & Analysis
- Market Mechanics
- Constraint Map
- Competitive Temperature
- Actionable Opportunities (2024-26 Window)
- Go Forward Recommendations (by player type)
- What Success Looks Like
- Indian Market Forecasts (2023-2032)
- Indian Market by Clinical Area (2023-2032)
- Indian Market by Modality (2023-2032)
- Indian Market by Revenue Stream (2023-2032)
- Indian Market by Clinical Application (2023-2032)
- Indian Market by End-Use Organization (2023-2032)
- Indian Market by AI Technology (2023-2032)
- Markintel Solution Adoption & Growth Matrix - India
- Solution Classes and Action Cues
- Strategic Interpretation & Operating Roadmap
- One-Page Operating Checklist
- Markintel Ecosystem Collaboration Matrix - India
- Operating Roadmap: Leveraging India’s Collaboration Matrix
- Strategic Sequencing (2024 27)
- Execution Tips
- Key Metrics to Track
- Competitive Landscape - India
- Operating Roadmap
- GTM at a Glance - India
- GTM Readiness Radar - India
- Tiered Customer Landscape - India
- GTM Timeline - India
- Adjacency-Opportunity Radar - India
- Regulatory x Funding Heatmap - India
- White-Space Partnership Matrix
- Channel × Pricing Matrix
- Fast Strategic Cues (Do This First)
SECTION 7 - SOUTH KOREAN MARKET
- Market Summary & Overview: South Korea
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
- South Korea Market Context
- South Korean Market Forecasts (2023-2032)
- South Korean Market by Clinical Area (2023-2032)
- South Korean Market by Modality (2023-2032)
- South Korean Market by Revenue Stream (2023-2032)
- South Korean Market by Clinical Application (2023-2032)
- South Korean Market by End-Use Organization Type (2023-2032)
- South Korean Market by AI Technology (2023-2032)
- GTM at a Glance - South Korea
- Six-Pillar GTM Readiness Radar - South Korea
- Tiered Customer Landscape - South Korea
- Five-Step GTM Timeline - South Korea
- Adjacency-Opportunity Radar - South Korea
- Regulatory x Funding Heatmap - South Korea
- Whitespace Partnership Matrix - South Korea
- Channel × Pricing Matrix - Typical 2025 Deals
- Fast Strategic Cues
SECTION 8 - AUSTRALIAN MARKET
- Market Overview & Analysis
- Market Structure & Growth Drivers
- Segment Hotspots (Qualitative Sizing)
- Competitive Landscape
- Strategic Implications & GTM Priorities
- Action-Oriented Recommendations (Next 12 Months)
- Australian Market Forecasts (2023-2032)
- Australian Market by Clinical Area (2023-2032)
- Australian Market by Modality (2023-2032)
- Australian Market by Revenue Stream (2023-2032)
- Australian Market by Clinical Application (2023-2032)
- Australian Market by End-Use Organization (2023-2032)
- Australian Market by AI Technology (2023-2032)
- GTM at a Glance - Australia
- GTM Readiness Radar - Australia
- GTM Timeline - Australia
- Adjacency-Opportunity Radar - Australia
- Regulatory x Funding Heatmap
SECTION 9 - REST OF ASIA-PACIFIC (ROAPAC) MARKET
- Market Overview & Analysis
- Regional Clusters
- Market Dynamics - What’s Shaping Buying Decisions
- Actionable Recommendations
- Quick-Hit Opportunities by Cluster
- What Success Looks Like
- Rest of Asia-Pacific Market Forecasts (2023-2032)
- Rest of Asia-Pacific (ROAPAC) Market by Clinical Area (2023-2032)
- Rest of Asia-Pacific (ROAPAC) Market by Modality (2023-2032)
- Strategic Insights
- Rest of Asia-Pacific (ROAPAC) Market by Revenue Stream (2023-2032)
- Rest of Asia-Pacific (ROAPAC) Market by Clinical Application (2023-2032)
- Rest of Asia-Pacific (ROAPAC) Market by End-Use Organization (2023-2032)
- Rest of Asia-Pacific (ROAPAC) Market by AI Technology (2023-2032)
- GTM at a Glance - ROAPAC
- GTM Readiness Heatmap - ROAPAC Clusters
- Five-Step GTM Roll Out Timeline (2024 2029) - Keyed to Clusters
List of Tables
Table 1: AI Imaging Market by Country - APAC (2023 - 2032, USD Mill)
Table 2: Chinese Market by Clinical Area (2023-2032, USD Million)
Table 3: Chinese Market by Modality (2023-2032, USD Million)
Table 4: Chinese Market by Revenue Stream (2023-2032, USD Million)
Table 5: Chinese Market by Clinical Application (2023-2032, USD Million)
Table 6: Chinese Market by End-Use Organization (2023-2032, USD Million)
Table 7: Chinese Market by AI Technology (2023-2032, USD Million)
Table 8: Japanese Market by Clinical Area (2023-2032, USD Million)
Table 9: Japanese Market by Modality (2023-2032, USD Million)
Table 10: Japanese Market by Revenue Stream (2023-2032, USD Million)
Table 11: Japanese Market by Clinical Application (2023-2032, USD Million)
Table 12: Japanese Market by End-Use Organization (2023-2032, USD Million)
Table 13: Japanese Market by AI Technology (2023-2032, USD Million)
Table 14: Indian Market by Clinical Area (2023-2032, USD Million)
Table 15: Indian Market by Modality (2023-2032, USD Million)
Table 16: Indian Market by Revenue Stream (2023-2032, USD Million)
Table 17: Indian Market by Clinical Application (2023-2032, USD Million)
Table 18: Indian Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 19: Indian Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 20: South Korean Market by Clinical Area (2023-2032, USD Million)
Table 21: South Korean Market by Modality (2023-2032, USD Million)
Table 22: South Korean Market by Revenue Stream (2023-2032, USD Million)
Table 23: South Korean Market by Clinical Application (2023-2032, USD Million)
Table 24: South Korean Market End-Use Organization Type (2023-2032, USD Million)
Table 25: South Korean Market by AI Technology (2023-2032, USD Million)
Table 26: Australian Market by Clinical Area (2023-2032, USD Million)
Table 27: Australian Market by Modality (2023-2032, USD Million)
Table 28: Australian Market by Revenue Stream (2023-2032, USD Million)
Table 29:Australian Market by Clinical Application (2023-2032, USD Million)
Table 30: Australian Market by End-Use Organization (2023-2032, USD Million)
Table 31: Australian Market by AI Technology (2023-2032, USD Million)
Table 32: Rest of Asia-Pacific (ROAPAC) Market by Clinical Area (2023-2032, USD Million)
Table 33: Rest of Asia-Pacific (ROAPAC) Market by Modality (2023-2032, USD Million)
Table 34: Rest of Asia-Pacific (ROAPAC) Market by Revenue Stream (2023-2032, USD Million)
Table 35: Rest of Asia-Pacific (ROAPAC) Market by Clinical Application (2023-2032, USD Million)
Table 36: Rest of Asia-Pacific (ROAPAC) Market by End-Use Organization (2023-2032, USD Million)
Table 37: Rest of Asia-Pacific (ROAPAC) Market by AI Technology (2023-2032, USD Million)
List of Figures
Figure 1: APAC Top-Down Funnel - Country Group Mix (2023 vs 2032)
Figure 2: Bottom-up Attach Rate Flow APAC (Illustrative)
Figure 3: APAC Evidence -- Markintel Regional Model
Figure 4: Markintel GTM Growth and Maturity Matrix - APAC
Figure 5: Regulatory Velocity - APAC
Figure 6: OEM AI Attach Rate - APAC
Figure 7: AI Revenue Split - Factory vs Retrofi t - APAC
Figure 8: GTM Readiness Radar - APAC
Figure 9: Tiered Customer Landscape - APAC (2032)
Figure 10: GTM Timeline - APAC (2024-29)
Figure 11: Regulatory Funding Heatmap - APAC
Figure 12: Markintel Growth Maturity Matrix - China AI in Medical Imaging
Figure 13: Markintel Ecosystem Collaboration Matrix - China
Figure 14: Markintel Solution Adoption and Growth Matrix - China
Figure 15: GTM Readiness Radar - China
Figure 16: Tiered Customer Landscape - China (2032)
Figure 17: GTM Timeline - China (2024-29)
Figure 18: Adjacency-Opportunity Radar - China
Figure 19: Regulatory Funding Heatmap - China
Figure 20: Markintel Solution Adoption & Growth Matrix - Japan
Figure 21: Markintel Ecosystem Collaboration Matrix - Japan
Figure 22: GTM Readiness Radar - Japan
Figure 23: GTM Timeline - Japan
Figure 24: Adjacency Opportunity Radar - Japan
Figure 25: Regulatory Funding Heatmap - Japan
Figure 26: White Space Partnership Matrix - Japan
Figure 27: Markintel Solution Adoption & Growth Matrix - India
Figure 28: Markintel Ecosystem Collaboration Matrix - India
Figure 29: GTM Readiness Radar - India
Figure 30: Tiered Customer Landscape - India
Figure 31: GTM Timeline - India
Figure 32: Adjacency-Opportunity Radar - India
Figure 33: Regulatory x Funding Heatmap - India
Figure 34: Six-Pillar GTM Readiness Radar - South Korea
Figure 35: Tiered Customer Landscape - South Korea
Figure 36: Five-Step GTM Timeline - South Korea
Figure 37: Adjacency-Opportunity Radar - South Korea
Figure 38: Regulatory x Funding Heatmap - South Korea
Figure 39: GTM Readiness Radar - Australia
Figure 40: GTM Timeline - Australia
Figure 41: Adjacency-Opportunity Radar - Australia
Figure 42: Regulatory x Funding Heatmap
Figure 43: GTM Readiness Heatmap - ROAPAC Clusters
Figure 44: Five-Step GTM Roll Out Timeline (2024 2029) - ROAPAC
